Publications by authors named "Ryohei Sumitani"

Claim this Profile
S
Successful hemodialysis initiation in acquired hemophilia a managed with susoctocog alfa and emicizumab.
Ayano Kihara, Masanori Tamaki, Ryohei Sumitani, Chihiro Okinari, Miho Tada

CEN Case Rep· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel noninvasive parameters for diagnosis of liver involvement in patients with systemic AL amyloidosis.
Ryohei Sumitani, Hirokazu Miki, Shingen Nakamura, Masafumi Nakamura, Taiki Hori

Int J Hematol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of skeletal muscles during allogeneic stem-cell transplantation: a pilot study.
Yusaku Maeda, Shoichiro Takao, Shiori Morita, Shin Kondo, Michiko Yamashita, Ryohei Sumitani

BMJ Support Palliat Care· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a rapid and novel diagnostic technique for cardiac amyloidosis using Raman spectroscopy.
Mizuki Yoshimoto, Shin-Ichiro Yanagiya, Hiroki Takanari, Takeshi Honda, Yusaku Maeda, Ryohei Sumitani

Res Sq· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic haematopoietic stem cell transplantation and patient falls: impact of lower extremity muscle strength.
Shin Kondo, Tatsuro Inoue, Takashi Saito, Yuka Kawamura, Ayane Katayama, Ryohei Sumitani

BMJ Support Palliat Care· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effective Intractable Chylous Ascites Treatment by Lymphangiography with Lipiodol in a Patient with Follicular Lymphoma.
Ryohei Sumitani, Kohei Higashi, Masahiro Oura, Yusaku Maeda, Hikaru Yagi

Intern Med· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
False-Positive Galactomannan Test Results in Multiple Myeloma.
Shingen Nakamura, Yusaku Maeda, Ryohei Sumitani, Masahiro Oura, Kimiko Sogabe

Diseases· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elotuzumab-mediated ADCC with Th1-like Vγ9Vδ2 T cells to disrupt myeloma-osteoclast interaction.
Yusuke Inoue, Hirofumi Tenshin, Jumpei Teramachi, Ryohei Sumitani, Asuka Oda

Cancer Sci· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preparedness for the future in patients with relapsed or refractory hematopoietic malignancies in the treatment process: a qualitative study.
Kazuko Akashi, Yoshie Imai, Shingen Nakamura, Yusaku Maeda, Ryohei Sumitani

Ann Palliat Med· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute myeloid leukemia developed through myeloproliferative features during immunosuppressive therapy for juvenile idiopathic arthritis.
Masahiro Oura, Ryohei Sumitani, Yusaku Maeda, Hikaru Yagi, Mamiko Takahashi

J Med Invest· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toxoplasmic encephalitis with high Tl uptake and retention mimicking malignant lymphoma in a patient with human immunodeficiency virus infection.
Shingen Nakamura, Keijiro Hara, Tomoko Kobayashi, Ryohei Sumitani, Masahiro Oura

Parasitol Int· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ex vivo expansion and activation of Vγ9Vδ2 T cells by CELMoDs in combination with zoledronic acid.
Yusuke Inoue, Asuka Oda, Yusaku Maeda, Ryohei Sumitani, Masahiro Oura

Int J Hematol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Skeletal muscle mass during chemotherapy for haematological malignancies: a retrospective study.
Mamiko Takahashi, Shin Kondo, Kumiko Kagawa, Masafumi Nakamura, Yusaku Maeda, Ryohei Sumitani

BMJ Support Palliat Care· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute accumulation of PIM2 and NRF2 and recovery of β5 subunit activity mitigate multiple myeloma cell susceptibility to proteasome inhibitors.
Kimiko Sogabe, Shingen Nakamura, Yoshiki Higa, Hirokazu Miki, Asuka Oda, Ryohei Sumitani

Int J Hematol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute suppression of translation by hyperthermia enhances anti-myeloma activity of carfilzomib.
Tomoko Maruhashi, Hirokazu Miki, Kimiko Sogabe, Asuka Oda, Ryohei Sumitani

Int J Hematol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic efficacy of the resorcylic acid lactone LL-Z1640-2 for adult T-cell leukaemia/lymphoma.
Masahiro Oura, Takeshi Harada, Asuka Oda, Jumpei Teramachi, Atsushi Nakayama, Ryohei Sumitani

EJHaem· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanisms of preferential bone formation in myeloma bone lesions by proteasome inhibitors.
Emiko Nakaue, Jumpei Teramachi, Hirofumi Tenshin, Masahiro Hiasa, Takeshi Harada, Ryohei Sumitani

Int J Hematol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel antimyeloma therapeutic option with inhibition of the HDAC1-IRF4 axis and PIM kinase.
Takeshi Harada, Hiroto Ohguchi, Asuka Oda, Michiyasu Nakao, Jumpei Teramachi, Ryohei Sumitani

Blood Adv· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Xanthine Oxidase Inhibitor Febuxostat Suppresses Adipogenesis and Activates Nrf2.
Yoshiki Higa, Masahiro Hiasa, Hirofumi Tenshin, Emiko Nakaue, Mariko Tanaka, Ryohei Sumitani

Antioxidants (Basel)· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Primary cutaneous anaplastic large cell lymphoma with systemic progression responding to low-dose methotrexate therapy].
Ryohei Sumitani, Takeshi Harada, Masafumi Nakamura, Makiko Mizuguchi, Masahiro Oura

Rinsho Ketsueki· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The importance of retaining physical functions to prevent skeletal-related events in multiple myeloma patients with bone disease.
Hirokazu Miki, Shingen Nakamura, Masahiro Oura, Masafumi Nakamura, Ryohei Sumitani

EJHaem· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanical unloading aggravates bone destruction and tumor expansion in myeloma.
Kotaro Tanimoto, Masahiro Hiasa, Hirofumi Tenshin, Jumpei Teramachi, Asuka Oda, Ryohei Sumitani

Haematologica· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TGF-β-activated kinase-1 inhibitor LL-Z1640-2 reduces joint inflammation and bone destruction in mouse models of rheumatoid arthritis by inhibiting NLRP3 inflammasome, TACE, TNF-α and RANKL expression.
Hirofumi Tenshin, Jumpei Teramachi, Mohannad Ashtar, Masahiro Hiasa, Yusuke Inoue, Ryohei Sumitani

Clin Transl Immunology· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravenous busulfan-based conditioning with autologous stem cell transplantation for refractory B-cell lymphoma with central nervous system involvement.
Mamiko Takahashi, Ryohei Sumitani, Taiki Hori, Jumpei Murai, Shiyori Kawata

J Med Invest· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute Myeloid Leukemia Developing with Acute Pancreatitis Mimicking Autoimmune Pancreatitis.
Ryohei Sumitani, Taiki Hori, Jumpei Murai, Shiyori Kawata, Masahiro Oura

Intern Med· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis